Evaluation of Dhanyamla Dhara with Erand Bhrishta Haritaki in the Management of Rheumatoid Arthritis

A CLINICAL STUDY TO EVALUATE THE EFFICACY OF DHANYAMLA DHARA WITH ERAND BHRISHTA HARITAKI IN THE MANAGEMENT OF AMAVATA W.S.R TO RHEUMATOID ARTHRITIS ERAND BHRISHTA HARITAKI IN THE MANAGEMENT OF AMAVATA W S R TO RHEUMATOID ARTHRITIS - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/105652

Enrollment

Registered

2026-03-09

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M069- Rheumatoid arthritis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients of either sex with age between 20 and 60 years Willing and able to participate in the study Patient having signs & symptoms of Amavata w s r Rheumatoid arthritis with fulfilling Diagnostic criteria Chronicity less than 10 years Patients with postchikungunya Rheumatoid arthritis will be included if fulfilling ACR diagnostic criteria To be fit&willing for treatment

Exclusion criteria

Exclusion criteria: Patients having severe systemic diseases like cardiac disorders and Cancer Patients below 20 years and above 60 years Chronicity 10 or more years Patient not fit for Dhanyamla Dhara in respective group Patients having Gouty arthritis Osteo arthritis

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of Dhanyamla Dhara with Erand Bhrishta Haritaki in Amavata To asses changes in symptoms of Amavata Timepoint: 16 days	—

Secondary

Measure	Time frame
To improve the quality of life Timepoint: 16 days	—

Countries

India

Contacts

Public ContactDr Gyan Prakash Sharma

Post Graduate Institute of Ayurved

atreyagyan@gmail.com9829798701

Outcome results